Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Cash (2017 - 2025)

Puma Biotechnology's Change in Cash history spans 9 years, with the latest figure at -$23.9 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 1321.37% year-over-year to -$23.9 million; the TTM value through Dec 2025 reached -$39.6 million, down 157.61%, while the annual FY2025 figure was -$39.6 million, 157.61% down from the prior year.
  • Change in Cash reached -$23.9 million in Q4 2025 per PBYI's latest filing, down from -$1.1 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $25.2 million in Q3 2022 to a low of -$25.9 million in Q3 2021.
  • Average Change in Cash over 5 years is -$3.3 million, with a median of -$3.8 million recorded in 2021.
  • Peak YoY movement for Change in Cash: plummeted 3078.04% in 2021, then soared 229.9% in 2023.
  • A 5-year view of Change in Cash shows it stood at -$816000.0 in 2021, then plummeted by 115.56% to -$1.8 million in 2022, then skyrocketed by 229.9% to $2.3 million in 2023, then decreased by 14.4% to $2.0 million in 2024, then crashed by 1321.37% to -$23.9 million in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Change in Cash are -$23.9 million (Q4 2025), -$1.1 million (Q3 2025), and -$8.4 million (Q2 2025).